The inflammasome activation in macrophages, epithelial cells, and endothelial cells releases pro‐inflammatory cytokines, Interleukin (IL)‐1β and IL‐18, which produce neutrophilia and leukopenia, contributing to the pathogenic inflammation responsible for the severity of symptoms of COVID‐19 (24, 25). This evidence concerns the gene IL1B and COVID-19.